Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve With reference to our intimation dated 05th February, 2026 under Regulation 29 of the SEBI (LODR)Regulations, 2015 regarding Board Meeting to be held on Thursday, 12th February ,2026 for approval of Un-Audited Financial Results of the Company for the Quarter ended December 31st, 2025. This is to inform you thatdue to the unavailability of the auditor, who is currently unable to provide the Limited Review Report , the saidBoard Meeting has been postponed and rescheduled to be held on Saturday, 14th February, 2026.
Johnson Pharmacare Limited Press Release Feb 12 2026
Filed with BSE · · 1 page · English
Release
Johnson Pharmacare Limited on 6ix
Earlier from Johnson Pharmacare
- Johnson Pharmacare Limited Press Release Feb 09 2026
- Johnson Pharmacare Limited Press Release Feb 05 2026
- Johnson Pharmacare Limited Press Release Feb 02 2026
- Johnson Pharmacare Limited Press Release Jan 31 2026
- Johnson Pharmacare Limited Press Release Jan 24 2026
Later from Johnson Pharmacare
- Johnson Pharmacare Limited Press Release Feb 13 2026
- Johnson Pharmacare Limited Press Release Feb 16 2026
- Johnson Pharmacare Limited Press Release Mar 21 2026
- Johnson Pharmacare Limited Press Release Apr 13 2026
- Johnson Pharmacare Limited Press Release Apr 17 2026
Follow Johnson Pharmacare into a list and get an email when it puts out news.
Follow Johnson Pharmacare